Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GE HealthCare Technologies Inc.GEHC · Entity 1711 | CEO, PDx | September 03, 2026 | September 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GE HealthCare Technologies Inc.
Report date September 03, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 32,026 |
Reported balance
After 2026-09-03 transaction · row 1
1 source rowRow 1 · 2026-09-03 · Tax withholding · Disposed 718 · Balance 32,026 F1: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. |
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectBy share incentive plan trust | 59 |
Reported balance
Holding disclosure · report date 2026-09-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 59 |
Filing footnotes · ownership attribution and instrument terms
F1: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 4, 2026 20:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 718 | $70.56 | $50,662.08 |
DisclosureSEC source: 0001951605-26-000008 · wk-form4_1788554702.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,026 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:24 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 17,218 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0001951605-26-000006 · wk-form4_1772659488.xml · derivative · entry 3 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,218 Underlying: Common Stock, par value $0.01 per share · 17,218 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:24 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 6,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001951605-26-000006 · wk-form4_1772659488.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,744 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:17 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 3,261 | $79.20 | $258,271.20 |
DisclosureSEC source: 0001951605-26-000004 · wk-form4_1771373867.xml · nonDerivative · entry 2 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,195 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:17 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 6,938 | $0.00 | $0.00 |
DisclosureSEC source: 0001951605-26-000004 · wk-form4_1771373867.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,456 F1 · shares: Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. Read SEC document |
| February 01, 2026 Filed Feb 4, 2026 00:03 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 462 | $78.97 | $36,484.14 |
DisclosureSEC source: 0001951605-26-000002 · wk-form4_1770163403.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,518 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 00:44 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 13,231 | $0.00 Strike: $86.45 | $0.00 |
DisclosureSEC source: 0001628280-25-010707 · wk-form4_1741221839.xml · derivative · entry 4 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,231 Underlying: Common Stock, par value $0.01 per share · 13,231 shares Expires 2035-03-03 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 00:44 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 4,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-010707 · wk-form4_1741221839.xml · nonDerivative · entry 2 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,980 F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:30 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 2,140 | $87.35 | $186,929.00 |
DisclosureSEC source: 0001628280-25-009990 · wk-form4_1741127401.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,875 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2025 Filed Mar 6, 2025 00:44 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,521 | $87.35 | $132,859.35 |
DisclosureSEC source: 0001628280-25-010707 · wk-form4_1741221839.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,354 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:14 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 462 | $88.30 | $40,794.60 |
DisclosureSEC source: 0001628280-25-003715 · wk-form4_1738703667.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,015 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 03, 2024 Filed Aug 6, 2024 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,533 | $83.44 | $127,913.52 |
DisclosureSEC source: 0001628280-24-035172 · wk-form4_1722974712.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,477 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 9,202 | $0.00 Strike: $92.72 | $0.00 |
DisclosureSEC source: 0001628280-24-009080 · wk-form4_1709679248.xml · derivative · entry 7 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,202 Underlying: Common Stock, par value $0.01 per share · 9,202 shares Expires 2034-03-01 F5 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F5 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 3,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009080 · wk-form4_1709679248.xml · nonDerivative · entry 5 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,010 F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F4 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 3,059 | $91.28 | $279,225.52 |
DisclosureSEC source: 0001628280-24-009080 · wk-form4_1709679248.xml · nonDerivative · entry 4 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,775 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,717 | $91.28 | $156,727.76 |
DisclosureSEC source: 0001628280-24-009080 · wk-form4_1709679248.xml · nonDerivative · entry 3 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,834 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 2,140 | $91.28 | $195,339.20 |
DisclosureSEC source: 0001628280-24-009080 · wk-form4_1709679248.xml · nonDerivative · entry 2 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,551 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:54 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,309 | $91.28 | $119,485.52 |
DisclosureSEC source: 0001628280-24-009080 · wk-form4_1709679248.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,691 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,532 | $76.19 | $116,723.08 |
DisclosureSEC source: 0001628280-23-027761 · wk-form4_1691438746.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,493 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,275 | $0.00 Strike: $40.40 | $0.00 |
DisclosureSEC source: 0001628280-23-026750 · wk-form4_1691006724.xml · derivative · entry 4 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 13,275 shares Expires 2028-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis, of which 100% are fully exercisable immediately. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | SaleCommon Stock, par value $0.01 per share | 13,275 | $77.46 | $1,028,281.50 |
DisclosureSEC source: 0001628280-23-026750 · wk-form4_1691006724.xml · nonDerivative · entry 3 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,025 F2 · kind: Includes sale of approximately 6,923 shares of GE HealthCare common stock to cover the exercise price of the stock options. F3 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $77.45 to $77.55, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3). Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Exercise / conversionCommon Stock, par value $0.01 per share | 13,275 | $40.40 | $536,310.00 |
DisclosureSEC source: 0001628280-23-026750 · wk-form4_1691006724.xml · nonDerivative · entry 2 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | SaleCommon Stock, par value $0.01 per share | 2,334 | $76.55 | $178,667.70 |
DisclosureSEC source: 0001628280-23-026750 · wk-form4_1691006724.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,025 F1 · price: The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $76.55 to $76.59, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 00:52 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 763 | $75.04 | $57,255.52 |
DisclosureSEC source: 0001628280-23-006427 · wf-form4_167789110493534.xml · nonDerivative · entry 3 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,359 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:52 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 10,188 | $0.00 Strike: $75.30 | $0.00 |
DisclosureSEC source: 0001628280-23-006427 · wf-form4_167789110493534.xml · derivative · entry 4 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,188 Underlying: Common Stock, par value $0.01 per share · 10,188 shares Expires 2033-03-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:52 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 1,309 | $75.30 | $98,567.70 |
DisclosureSEC source: 0001628280-23-006427 · wf-form4_167789110493534.xml · nonDerivative · entry 2 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,122 F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:52 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 3,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006427 · wf-form4_167789110493534.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,431 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| February 09, 2023 Filed Dec 29, 2023 23:01 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 6,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-042946 · wk-form4_1703890860.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,000 F1 · date: Inadvertently filed late due to an administrative error. F2 · shares: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs vest on March 1, 2024, subject to the reporting person's continued employment. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 23:02 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 17,244 | Not disclosed Strike: $70.01 | Not disclosed |
DisclosureSEC source: 0001628280-23-002268 · wf-form4_167546535084139.xml · derivative · entry 2 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,244 Underlying: Common Stock, par value $0.01 per share · 17,244 shares Expires 2033-02-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 23:02 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 1,964 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-002268 · wf-form4_167546535084139.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,779 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 1,964 newly awarded restricted stock units and 22,815 previously reported restricted stock units. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 9,106 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 16 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,106 Underlying: Common stock, par value $0.01 per share · 9,106 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F8 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. F8 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 5,568 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 15 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,568 Underlying: Common stock, par value $0.01 per share · 5,568 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F7 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. F7 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 6,519 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 14 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,519 Underlying: Common stock, par value $0.01 per share · 6,519 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F6 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024. F6 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 1,622 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 13 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,622 Underlying: Common stock, par value $0.01 per share · 1,622 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F5 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023. F5 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 10,820 | Not disclosed Strike: $63.51 | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 12 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,820 Underlying: Common stock, par value $0.01 per share · 10,820 shares Expires 2030-03-02 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is fully exercisable immediately and 50% will become exercisable on March 2, 2023. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 1,614 | Not disclosed Strike: $51.67 | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 11 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,614 Underlying: Common stock, par value $0.01 per share · 1,614 shares Expires 2029-04-11 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 3,106 | Not disclosed Strike: $57.74 | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 10 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,106 Underlying: Common stock, par value $0.01 per share · 3,106 shares Expires 2029-03-19 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 13,275 | Not disclosed Strike: $40.40 | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 9 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,275 Underlying: Common stock, par value $0.01 per share · 13,275 shares Expires 2028-12-21 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 4,592 | Not disclosed Strike: $76.66 | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 8 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,592 Underlying: Common stock, par value $0.01 per share · 4,592 shares Expires 2028-03-19 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 5,877 | Not disclosed Strike: $99.21 | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 7 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,877 Underlying: Common stock, par value $0.01 per share · 5,877 shares Expires 2027-11-17 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 5,051 | Not disclosed Strike: $161.30 | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 6 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,051 Underlying: Common stock, par value $0.01 per share · 5,051 shares Expires 2026-09-30 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 3,672 | Not disclosed Strike: $135.92 | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 5 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,672 Underlying: Common stock, par value $0.01 per share · 3,672 shares Expires 2025-09-11 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 3,329 | Not disclosed Strike: $142.15 | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 4 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,329 Underlying: Common stock, par value $0.01 per share · 3,329 shares Expires 2024-09-05 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 343 | Not disclosed Strike: $142.15 | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 3 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343 Underlying: Common stock, par value $0.01 per share · 343 shares Expires 2024-09-05 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 1,653 | Not disclosed Strike: $129.52 | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · derivative · entry 2 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,653 Underlying: Common stock, par value $0.01 per share · 1,653 shares Expires 2023-09-13 F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:45 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon stock, par value $0.01 per share | 59 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001111 · doc4.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: Not disclosed Ownership: Indirect · By share incentive plan trust Disclosed balance after: 59 F1 · shares: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.